| Wearables and the medical revolution |
29 |
| 'Your DNA, Your Say': global survey gathering attitudes toward genomics: design, delivery and methods |
8 |
| Analytical validation of a psychiatric pharmacogenomic test |
6 |
| Precision medicine: a call for increased pharmacogenomic education |
6 |
| Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer |
5 |
| The clinical application of gene editing: ethical and social issues |
5 |
| Enhancing diversity to reduce health information disparities and build an evidence base for genomic medicine |
5 |
| Use of combinatorial pharmacogenomic guidance in treating psychiatric disorders |
5 |
| Identifying novel candidate biomarkers of RCC based on WGCNA analysis |
4 |
| ALK-rearranged adenocarcinoma transformed to small-cell lung cancer: a new entity with specific prognosis and treatment? |
4 |
| miRNA 196a2(rs11614913) & 146a(rs2910164) polymorphisms & breast cancer risk for women in an Iranian population |
4 |
| Efficacy and safety of direct-acting antivirals for treatment-naive patients with genotype 1 hepatitis C virus infection |
3 |
| Continuing war on pain: a personalized approach to the therapy with nonsteroidal anti-inflammatory drugs and opioids |
3 |
| From helices to health: undergraduate medical education in genetics and genomics |
3 |
| Preparing next-generation scientists for biomedical big data: artificial intelligence approaches |
3 |
| MTHFR polymorphisms as risk for male infertility in Pakistan and its comparison with socioeconomic status in the world |
3 |
| Clinical application of pharmacogenetics in pain management |
3 |
| Association of genetic polymorphisms in immune-related lncRNA with osteoarthritis susceptibility in Chinese Han population |
3 |
| The polymorphisms of growth factor genes (VEGFA & EGF) were associated with response to acitretin in psoriasis |
2 |
| Protein inhibitor of activated STAT genes are differentially expressed in breast tumor tissues |
2 |
| The effect of CYP2C19 genotype-guided antiplatelet therapy on outcomes of selective percutaneous coronary intervention patients: an observational study |
2 |
| Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium |
2 |
| Clinical outcomes in men with prostate cancer who selected active surveillance using a clinical cell cycle risk score |
2 |
| Biobanking as a necessary tool for research in the field of personalized medicine in the scientific medical center |
2 |
| Challenges in anesthesia personalization: resolving the pharmacogenomic puzzle |
2 |
| The association study of CLOCK gene polymorphisms with antidepressant effect in Chinese with major depressive disorder |
2 |
| Toward greater understanding of patient decision-making around genome sequencing |
2 |
| The Undergraduate Training in Genomics (UTRIG) Initiative: early & active training for physicians in the genomic medicine era |
2 |
| The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costs |
2 |
| Oxidized-LDL is a useful marker for predicting the very early coronary artery disease and cardiovascular outcomes |
2 |
| Provider engagement in precision oncology education: an exploratory analysis of online continuing medical education data |
2 |
| Preventive effects of oxytocin and oxytocin receptor in breast cancer pathogenesis |
2 |
| APOE genotypes in Lebanon: distribution and association with hypercholesterolemia and Alzheimer's disease |
2 |
| Bioinformatic validation identifies candidate key genes in diffuse large-B cell lymphoma |
1 |
| Survivin c.-31G > C (rs9904341) gene transversion and urinary system cancers risk: a systematic review and a meta-analysis |
1 |
| Implementing a personalized medicine cancer program in a community cancer system |
1 |
| The public perception of the facilitators and barriers to implementing personalized medicine: a systematic review |
1 |
| Toward multiomics-based next-generation diagnostics for precision medicine |
1 |
| Clinical and research applications of a brain tumor tissue bank in the age of precision medicine |
1 |
| Current applications of precision medicine: a bibliometric analysis |
1 |
| Association between functional polymorphisms in the promoter of the miR-143/145 cluster and risk of conotruncal heart defects |
1 |
| Association between expression of long noncoding RNAs in placenta and pregnancy features |
1 |
| Cost-effectiveness of BRCA1/2 mutation profiling to target olaparib use in patients with metastatic breast cancer |
1 |
| Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine |
1 |
| Pharmacogenetics of novel oral anticoagulants: a review of identified gene variants & future perspectives |
1 |
| Functional consequences of genetic variation in sodium channel modifiers in early onset lone atrial fibrillation |
1 |
| Personalized medicine in inflammatory cardiomyopathy |
1 |
| Zinc finger and interferon-stimulated genes play a vital role in TB-IRIS following HAART in AIDS |
1 |
| Effects of immuno-related gene polymorphisms on a bispecific antibody targeting colorectal cancer cell |
1 |
| Polymorphism of PARP-1 indicates an increased risk and a worse initial severity of ischemic stroke |
1 |
